Compare Amphastar Pharmaceuticals Inc (AMPH) vs Sprott Uranium Miners ETF (URNM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Amphastar Pharmaceuticals Inc vs Sprott Uranium Miners ETF — how do they compare? Amphastar Pharmaceuticals Inc trades at $20.39 (market cap $868.62M), while Sprott Uranium Miners ETF trades at $55.96. Which is the better fit depends on your goals.
| AMPH | URNM | |
|---|---|---|
Market Cap | $868.62M | — |
Sector | Health | Commodities - Metals/Agriculture |
52-Week High | $30.81 | $83.99 |
52-Week Low | $16.87 | $44.14 |
Enterprise Value | $1.27B | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Amphastar Pharmaceuticals Inc
Amphastar is a specialty pharmaceutical company that develops and markets injectable, intranasal, and inhalation products. Its portfolio includes both complex generic drugs and proprietary delivery systems.
Read more on AMPH →About Sprott Uranium Miners ETF
URNM is a pure-play ETF that invests in the global uranium industry. It provides exposure to companies involved in the mining, exploration, and production of uranium, as well as physical uranium holdings, with top assets like Cameco, Uranium Energy Corp, and the Sprott Physical Uranium Trust.
Read more on URNM →
